Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Rodríguez Fernández-Freire, Lourdes
143  Ergebnisse:
Personensuche X
?
1

A non-interventional, multicenter study to characterize the..:

Puig, Lluis ; Izu Belloso, Rosa ; Rivera-Diez, Raquel...
Dermatology.  , 2024
Link: https://doi.org/10.1159/..
 
?
2

Efficacy and safety of biological therapy in patients with ..:

Ortiz Álvarez, Juan ; Rodríguez Fernández-Freire, Lourdes ; Hernández-Rodríguez, Juan Carlos...
Archives of Dermatological Research.  315 (2022)  4 - p. 1045-1048 , 2022
Link: https://doi.org/10.1007/..
 
?
3

Tildrakizumab: Efficacy, Safety and Survival in Mid-Term (5..:

Ruiz-Villaverde, Ricardo ; Rodriguez Fernandez-Freire, Lourdes ; Font-Ugalde, Pilar.
Journal of Clinical Medicine.  11 (2022)  17 - p. 5098 , 2022
Link: https://doi.org/10.3390/..
 
?
4

Mixedema palpebral por amiodarona:

Serrano, Amalia ; del Canto, Susana ; Hernández-Montoya, Carlos...
Actas Dermo-Sifiliográficas.  94 (2003)  6 - p. 406-408 , 2003
Link: https://doi.org/10.1016/..
 
?
5

Bimekizumab: Short-Term Effectiveness and Safety in Real Cl..:

Ruiz-Villaverde, Ricardo ; Rodriguez-Fernandez-Freire, Lourdes ; Cebolla-Verdugo, Marta...
Life.  14 (2024)  3 - p. 281 , 2024
Link: https://doi.org/10.3390/..
 
?
6

Effectiveness, survival and safety of guselkumab attending ..:

Ruiz-Villaverde, Ricardo ; Rodriguez-Fernandez-Freire, Lourdes ; Armario-Hita, Jose C....
F1000Research.  11 (2022)  - p. 1178 , 2022
Link: https://doi.org/10.12688..
 
?
7

Effectiveness, survival and safety of guselkumab attending ..:

Ruiz-Villaverde, Ricardo ; Rodriguez-Fernandez-Freire, Lourdes ; Armario-Hita, Jose C....
F1000Research.  11 (2022)  - p. 1178 , 2022
Link: https://doi.org/10.12688..
 
?
8

Risankizumab: Efficacy, Safety, and Survival in the Mid-Ter..:

Ruiz-Villaverde, Ricardo ; Rodriguez-Fernandez-Freire, Lourdes ; Pérez-Gil, Amalia..
Life.  12 (2022)  11 - p. 1883 , 2022
Link: https://doi.org/10.3390/..
 
?
9

Super-Responders in Moderate–Severe Psoriasis under Guselku..:

Ruiz-Villaverde, Ricardo ; Vasquez-Chinchay, Fiorella ; Rodriguez-Fernandez-Freire, Lourdes...
Life.  12 (2022)  9 - p. 1412 , 2022
Link: https://doi.org/10.3390/..
 
?
10

Efficacy of secukinumab in psoriasis and psoriatic arthriti..:

Ruiz-Villaverde, Ricardo ; Rodriguez-Fernandez-Freire, Lourdes ; Galán-Gutierrez, Manuel.
Medicina Clínica (English Edition).  154 (2020)  9 - p. 370-371 , 2020
Link: https://doi.org/10.1016/..
 
?
11

41808 Effectiveness, safety and survival of guselkumab in p..:

Fernandez-Freire, Lourdes Rodriguez ; Villaverde, Ricardo Ruiz ; Armario Hita, Jose Carlos...
Journal of the American Academy of Dermatology.  89 (2023)  3 - p. AB154 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Incidence of severe COVID-19 outcomes in psoriatic patients..:

Baniandrés-Rodríguez, Ofelia ; Vilar-Alejo, Jaime ; Rivera, Raquel...
Journal of the American Academy of Dermatology.  84 (2021)  2 - p. 513-517 , 2021
Link: https://doi.org/10.1016/..
 
?
13

Long-term safety of nine systemic medications for psoriasis..:

Daudén, Esteban ; Carretero, Gregorio ; Rivera, Raquel...
Journal of the American Academy of Dermatology.  83 (2020)  1 - p. 139-150 , 2020
Link: https://doi.org/10.1016/..
 
?
14

The risk of urinary tract infections in patients with psori..:

Sahuquillo-Torralba, Antonio ; Carretero, Gregorio ; Rivera, Raquel...
Journal of the American Academy of Dermatology.  82 (2020)  3 - p. 738-741 , 2020
Link: https://doi.org/10.1016/..
 
?
15

Current status of multidisciplinary care in psoriatic arthr..:

Queiro, Rubén ; Coto, Pablo ; Joven, Beatriz...
Reumatología Clínica (English Edition).  16 (2020)  1 - p. 24-31 , 2020
Link: https://doi.org/10.1016/..
 
1-15